Literature DB >> 280402

Razoxane in treatment of acute myeloid leukaemia.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 280402      PMCID: PMC1608210          DOI: 10.1136/bmj.2.6145.1161

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  4 in total

1.  Razoxane in treatment of acute myeloid leukaemia.

Authors:  M Bhavnani; K Dhir; I W Delamore
Journal:  Br Med J       Date:  1978-09-16

2.  Cumulative cytostatic effect of ICRF 159.

Authors:  R C Hallowes; D G West; K Hellmann
Journal:  Nature       Date:  1974-02-15       Impact factor: 49.962

3.  Mode of action of the cytostatic agent "ICRF 159".

Authors:  H B Sharpe; E O Field; K Hellmann
Journal:  Nature       Date:  1970-05-09       Impact factor: 49.962

4.  Comparative study of early effects of epipodophyllotoxin derivatives and other cytostatic agents on mastocytoma cultures.

Authors:  A Grieder; R Maurer; H Stähelin
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.